Literature DB >> 16831911

M-CSF, c-Fms, and signaling in osteoclasts and their precursors.

F Patrick Ross1.   

Abstract

Prevention of conditions, such as osteoporosis, requires an understanding of the molecular mechanisms of bone resorption. The understanding that cells of the myeloid lineage are osteoclast precursors suggests that macrophage colony-stimulating factor (M-CSF) plays an important role in osteoclast biology. Signals generated by the binding of M-CSF to the cell-surface receptor c-Fms appear to trigger events leading to osteoclast differentiation. We have created a chimeric variant of the c-Fms receptor, which has allowed study of downstream events activated by M-CSF in a model more relevant to normal physiology than prior studies, which have relied on myeloid tissues. Our studies suggest novel regulatory signaling pathways initiated via the c-Fms receptor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831911     DOI: 10.1196/annals.1346.014

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  57 in total

1.  Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma.

Authors:  Linlin Xu; Khalid S Mohammad; Hao Wu; Colin Crean; Bradley Poteat; Yinghua Cheng; Angelo A Cardoso; Christophe Machal; Helmut Hanenberg; Rafat Abonour; Melissa A Kacena; John Chirgwin; Attaya Suvannasankha; Edward F Srour
Journal:  Cancer Res       Date:  2016-09-07       Impact factor: 12.701

2.  Protein tyrosine phosphatase epsilon regulates integrin-mediated podosome stability in osteoclasts by activating Src.

Authors:  Shira Granot-Attas; Chen Luxenburg; Eynat Finkelshtein; Ari Elson
Journal:  Mol Biol Cell       Date:  2009-08-19       Impact factor: 4.138

Review 3.  Osteoporosis and polypharmacy.

Authors:  M Gosch; M Jeske; C Kammerlander; T Roth
Journal:  Z Gerontol Geriatr       Date:  2012-08       Impact factor: 1.281

4.  Thermally induced osteocyte damage initiates pro-osteoclastogenic gene expression in vivo.

Authors:  Eimear B Dolan; David Tallon; Wing-Yee Cheung; Mitchell B Schaffler; Oran D Kennedy; Laoise M McNamara
Journal:  J R Soc Interface       Date:  2016-06       Impact factor: 4.118

5.  Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice.

Authors:  Anna M Mattson; Dana L Begun; David H H Molstad; Margaret A Meyer; Merry Jo Oursler; Jennifer J Westendorf; Elizabeth W Bradley
Journal:  J Biol Chem       Date:  2019-06-12       Impact factor: 5.157

6.  Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations.

Authors:  Oran D Kennedy; Brad C Herman; Damien M Laudier; Robert J Majeska; Hui B Sun; Mitchell B Schaffler
Journal:  Bone       Date:  2012-02-09       Impact factor: 4.398

7.  The relative timing of exposure to phagocytosable particulates and to osteoclastogenic cytokines is critically important in the determination of myeloid cell fate.

Authors:  Douglas E James; Bryan J Nestor; Thomas P Sculco; Lionel B Ivashkiv; F Patrick Ross; Steven R Goldring; P Edward Purdue
Journal:  J Immunol       Date:  2010-06-11       Impact factor: 5.422

8.  Src-like adaptor protein regulates osteoclast generation and survival.

Authors:  Hyun-Ju Kim; Wei Zou; Yuji Ito; Shin-Yoon Kim; Jean Chappel; F Patrick Ross; Steven L Teitelbaum
Journal:  J Cell Biochem       Date:  2010-05       Impact factor: 4.429

9.  NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism.

Authors:  Zhenqiang Yao; Lianping Xing; Brendan F Boyce
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

10.  The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumors.

Authors:  Allan Lipton; Robert Uzzo; Robert J Amato; Georgiana K Ellis; Behrooz Hakimian; G David Roodman; Matthew R Smith
Journal:  J Natl Compr Canc Netw       Date:  2009-10       Impact factor: 11.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.